VeriMomacetyl farnesylcysteine hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
Related ingredients
Frequently asked questions
- acetyl farnesylcysteine hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
- acetyl farnesylcysteine emzirirken güvenli mi?
- No evidence of reproductive or lactation‑related toxicity in the scientific literature or regulatory assessments. Dermal application to the breast could lead to low but measurable maternal systemic exposure (as for pregnancy), so exposure given as 1; no data show transfer into breastmilk or effects on nursing infants.
- acetyl farnesylcysteine bebek cildi için güvenli mi?
- No infant‑specific toxicology found. Because topical AFC shows measurable activity/absorption in skin studies, baby exposure is increased by +1 to account for immature barrier and higher surface‑area‑to‑weight (adult e=1 → infant e=2). No data indicate infant‑specific hazard or mechanisms, so h and m remain 0.
- VeriMom acetyl farnesylcysteine nasıl puanlıyor?
- VeriMom acetyl farnesylcysteine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte acetyl farnesylcysteine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.